Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


Affiliata alla Society of Radiopharmaceutical Sciences e all'International Research Group of Immunoscintigraphy
Pubblicazione segnalata su: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SCIE), Scopus
Impact Factor 1.795


Trimestrale

pISSN 1824-4785

eISSN 1827-1936

Gli articoli più letti nelle ultime tre settimane

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 June;64(2):152-61
Immunoscore and its introduction in clinical practice
Jérôme GALON *, Anastasia LANZI

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):355-70
CT radiomics and PET radiomics: ready for clinical implementation?
Marta BOGOWICZ *, Diem VUONG, Martin W. HUELLNER, Matea PAVIC, Nicolaus ANDRATSCHKE, Hubert S. GABRYS, Matthias GUCKENBERGER, Stephanie TANADINI-LANG

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):323-38
Machine learning for radiomics-based multimodality and multiparametric modeling
Lise WEI, Sarah OSMAN, Mathieu HATT, Issam EL NAQA *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 September;64(3):250-64
Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy
Maaike DOTINGA *, Dennis VRIENS, Floris van VELDEN, Linda HEIJMEN, James NAGARAJAH, Rodney HICKS, Ellen KAPITEIJN, Lioe-Fee de GEUS-OEI

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 June;64(2):162-74
The LIPI score and inflammatory biomarkers for selection of patients with solid tumors treated with checkpoint inhibitors
Jose C. BENITEZ, Gonzalo RECONDO, Elie RASSY, Laura MEZQUITA *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):254-66
Role of amino-acid PET in high-grade gliomas: limitations and perspectives
Antoine VERGER *, Javier ARBIZU, Ian LAW

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2016 September;60(3):236-51
Acute myocardial infarction
Christoph RISCHPLER

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):150-8
Response assessment of bone metastatic disease: seeing the forest for the trees
 RECIST, PERCIST, iRECIST, and PCWG-2
Angelo CASTELLO, Egesta LOPCI *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 June;62(2):152-64
How to use PET/CT in the evaluation of response to radiotherapy
Pierre DECAZES *, Sébastien THUREAU, Bernard DUBRAY, Pierre VERA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):72-8
Differential diagnostic ability of 18F-FDG PET/CT radiomics features between renal cell carcinoma and renal lymphoma
Sha ZHU, Hui XU, Chuyu SHEN, Yingjie WANG, Wenting XU, Shihao DUAN, Hanxiao CHEN, Xuejin OU, Linyan CHEN, Xuelei MA *

inizio pagina